Inventor
WONG DAVID T
US40 patents
⚠️ This page may combine multiple inventors who share the name “WONG DAVID T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
28 patentsUS5023269AJun 11, 1991
3-aryloxy-3-substituted propanamines
LILLY CO ELI194 citations99
US4956388ASep 11, 1990
3-aryloxy-3-substituted propanamines
LILLY CO ELI158 citations99
US5614523AMar 25, 1997
Compounds having effects on serotonin-related systems
LILLY CO ELI115 citations98
US5532244AJul 2, 1996
Potentiation of drug response
LILLY CO ELI107 citations98
US5789402AAug 4, 1998
Compounds having effects on serotonin-related systems
LILLY CO ELI103 citations97
US5627196AMay 6, 1997
Compounds having effects on serotonin-related systems
LILLY CO ELI99 citations97
US5135947AAug 4, 1992
1-phenyl-3-naphthalenyloxypropanamines and their use as selective serotonin reuptake inhibitors
LILLY CO ELI52 citations96
US5552429ASep 3, 1996
Potentiation of drug response
LILLY CO ELI66 citations95
US5532268AJul 2, 1996
Potentiation of drug response
LILLY CO ELI37 citations95
US5532250AJul 2, 1996
Potentiation of drug response
LILLY CO ELI30 citations95
US5013761AMay 7, 1991
Serotonin antagonists
LILLY CO ELI78 citations95
US5356934AOct 18, 1994
Selected serotonin subtype receptor agonist to treat sleep apnea
LILLY CO ELI48 citations93
US5958429ASep 28, 1999
Potentiation of serotonin response
LILLY CO ELI44 citations92
US5538992AJul 23, 1996
Potentiation of drug response
LILLY CO ELI20 citations92
US5532264AJul 2, 1996
Potentiation of drug response
LILLY CO ELI23 citations92
US5281624AJan 25, 1994
N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
LILLY CO ELI37 citations92
US5250571AOct 5, 1993
(S)-norfluoxetine in method of inhibiting serotonin uptake
LILLY CO ELI23 citations92
US4647591AMar 3, 1987
Method for improving memory
LILLY CO ELI35 citations86
US5238959AAug 24, 1993
3-phenyloxy-3-phenyl propanamines
LILLY CO ELI19 citations82
US4513135AApr 23, 1985
Diaryl-pyrazine derivatives affecting GABA binding
LILLY CO ELI20 citations82
US5420294AMay 30, 1995
Cycloalkylaminoalkoxyindoles
LILLY CO ELI15 citations81
US5250572AOct 5, 1993
(R)-norfluoxetine in method for occupying serotonin IC receptors
LILLY CO ELI9 citations74
US4996235AFeb 26, 1991
3,4-diphenylbutanamines
LILLY CO ELI13 citations74
US6172073B1Jan 9, 2001
Compounds having effects on serotonin-related systems
LILLY CO ELI12 citations73
US4528290AJul 9, 1985
Stimulating dopamine D-1 receptors
LILLY CO ELI6 citations73
US4876282AOct 24, 1989
1-Phenylalkylamines as selective serotonin uptake inhibitors
LILLY CO ELI5 citations63
US4585861AApr 29, 1986
1,2,4-triazine derivatives
LILLY CO ELI1 citations52
US5554640ASep 10, 1996
Use of propanolamine derivatives as selective 5-HT1 antagonists
LILLY CO ELI0 citations51
WONG DAVID T
5 patentsUS9689039B2Jun 27, 2017
Salivary biomarkers for lung cancer detection
WONG DAVID T20 citations91
US10023903B2Jul 17, 2018
Saliva collection, processing, stabilization, and storage method
WONG DAVID T1 citations51
US9624547B2Apr 18, 2017
Salivary transcriptomic and proteomic biomarkers for breast cancer detection
WONG DAVID T1 citations51
US9932635B2Apr 3, 2018
Method for exosomal biomarker detection by electric field-induced release and measurement
WONG DAVID T0 citations50
US9939442B2Apr 10, 2018
Salivary biomarkers for gastric cancer detection
WONG DAVID T0 citations41